Avatar photo

Z. Beketova

Non-metabolic/-Alcoholic Fatty Liver Disease: A Review

Fatty liver disease can be caused by many different autosomal recessive diseases. One includes Wilson’s disease, a condition which leads to abnormal copper accumulation in multiple organs. Cirrhosis is common in up to 30% of cases, as well as steatosis and steatohepatitis. Cystic fibrosis is another example, where steatosis is common and liver disease occurs in 0.1-3.6% of patients. Furthermore, alpha-1-antitrypsin deficiency and lysosomal acid lipase deficiency have been linked to steatosis accumulation, although have little research into their pathogenesis.

Read MoreNon-metabolic/-Alcoholic Fatty Liver Disease: A Review

Inflammation in Non-alcoholic Fatty Liver Disease: Part 1

Non-alcoholic fatty liver disease (NAFLD) has a more progressive form, non-alcoholic steatohepatitis (NASH). In both conditions, inflammation is a key driver of the pathogenesis. There are various causes of metabolic injury in the conditions, leading to the activation of different immune cells such as hepatic Kupffer cells.

Read MoreInflammation in Non-alcoholic Fatty Liver Disease: Part 1

Inflammation in Non-alcoholic Fatty Liver Disease: Part 2

Non-alcoholic fatty liver disease (NAFLD) has a more progressive form, non-alcoholic steatohepatitis (NASH). In both conditions, inflammation is a key driver of the pathogenesis. Current treatments mostly focus on promoting weight loss (through encouraging lifestyle changes, or, if necessary, bariatric surgery) and improving comorbidities through pharmacotherapy, such as type 2 diabetes.

Read MoreInflammation in Non-alcoholic Fatty Liver Disease: Part 2